What did Martin Shkreli do with the Wu-Tang album?
In July, the government agency said it offloaded the album to an undisclosed buyer to satisfy part of a $7.3 million forfeiture judgment against Shkreli, who is serving a seven-year sentence for security fraud. That buyer, PleasrDAO, revealed itself via Twitter on Wednesday, writing: “#Breaking Wu-Tang album secured.”
Does Martin Shkreli still have the Wu-Tang album?
A one-of-a-kind album by the hip-hop group Wu-Tang Clan that was once owned by notorious “pharma bro” Martin Shkreli finally was sold Tuesday by the U.S. government, more than three years after Shkreli forfeited the album as part of his conviction for securities fraud.
How much did Martin Shkreli buy the Wu-Tang album for?
$4 million
The government sold “Once Upon a Time in Shaolin” to satisfy a judgment against its first owner, Martin Shkreli. It ended up with a collective called PleasrDAO that paid an intermediary $4 million.
Who owns rare Wu-Tang album?
PleasrDAO
Now, the New York Times has revealed that the new owner of Once Upon A Time In Shaolin is the crypto group PleasrDAO, which paid $4 million in cryptocurrency, via an intermediary, for the privilege. An NFT (what else?) acts as the ownership deed for the physical record.
Who disrespected Wu-Tang?
An individual known only as Juror No. 59 was dismissed by the court, for example, after letting it be known that he could not be unbiased toward Shkreli because “he disrespected the Wu-Tang Clan.” Shkreli won Once Upon A Time In Shaolin, Wu-Tang Clan’s one-of-a-kind album recorded in secret, at an auction in 2015.
What is Popa Wu real name?
While no cause of death was given, according to The Source, Popa Wu — who was also known as Freedum Allah — died at his home in Brooklyn.
Does Shkreli still have money?
In June 2017, Reuters reported that Shkreli had reported his net worth at $70 million after being arrested in 2015 and that his attorney Benjamin Brafman, in a hearing before Judge Kiyo Matsumoto, had conceded that his client still owned shares of Turing Pharmaceuticals worth between $30 and $50 million.